UnitedHealth Stock Rises After Raising Profit Outlook

UnitedHealth Group reported first-quarter 2026 results that beat Wall Street expectations. The healthcare giant posted revenue of $111.7 billion, a 2% year-over-year increase that surpassed the consensus estimate of $109.6 billion.

A key highlight was the improvement in medical costs. The medical cost ratio, a critical measure of spending on patient care, fell to 83.9%, down 90 basis points from the same period last year. This indicates the company is effectively managing its largest expense.

The company's two main segments showed mixed results. Its UnitedHealthcare insurance arm saw revenue grow 2% to $86.3 billion, with operating margins expanding. However, its Optum Health services segment reported a 3% revenue decline, attributed to having fewer patients in value-based care arrangements.

Strategically, UnitedHealth agreed to acquire Alegeus Technologies, a platform for managing consumer-directed health accounts like HSAs and FSAs. The company also continued its share repurchase program, returning capital to shareholders.

The raised profit outlook is the most significant takeaway for the market. UnitedHealth increased its full-year 2026 adjusted EPS guidance to over $18.25, up from a previous forecast of over $17.75. This new target is well above the analyst consensus of $17.86, demonstrating management's confidence.

The lower medical cost ratio directly boosts profitability. When UnitedHealth spends less on medical claims than anticipated, more revenue flows to the bottom line. This cost discipline, even as the company invests in technology and personnel, shows operational efficiency.

The recent finalization of 2027 Medicare Advantage payment rates by the U.S. government is a major tailwind. The rates are projected to increase payments to plans by 2.48%, which is better than the industry initially expected. This favorable policy environment supports future growth for UnitedHealth's large Medicare business.

Together, these factors—strong cost control, raised guidance, and supportive government policy—paint a picture of a company executing well in a stable regulatory landscape. This combination is why investor sentiment turned sharply positive, driving the stock higher.